Home › Non-Muscle Invasive Bladder Cancer › Michigan
Non-Muscle Invasive Bladder Cancer clinical trials in Michigan
7 studies for Non-Muscle Invasive Bladder Cancer are looking for participants at sites in Michigan.
Cities in Michigan
A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
- Comprehensive Urology, Royal Oak
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT06919965A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States
- Michigan Institute of Urology, Troy
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07309445Exploration of Novel AI-enabled Blue Light Enhanced Cystoscopy
- Regents of the University of Michigan, Ann Arbor
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 4, 2026 · NCT07144319FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
- Barbara Ann Karmanos Cancer Institute, Detroit
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 20, 2026 · NCT05614739LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
- Henry Ford Health System, Detroit
- Corewell Health Medical Group and Spectrum Health Hospitals, Grand Rapids
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 7, 2026 · NCT04752722A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer
- Michigan Institute of Urology, Troy
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated May 27, 2026 · NCT05710848ResQ133A-NMIBC: Intravesical Recombinant Mycobacterium (rMBCG) in Participants With NMIBC Eligible to Receive Intravesical Tice BCG
- Michigan Institute of Urology & Solaris Health, Troy
RecruitingPhase 1/2
Ages 18 to 85 · All sexes · Updated Mar 27, 2026 · NCT06800963From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.